Literature DB >> 9069471

Clinical rationale of genetic testing in dementia.

G B Frisoni, M Trabucchi.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9069471      PMCID： PMC1064145          DOI： 10.1136/jnnp.62.3.217

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  84 in total

1.  Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease.

Authors:  H Chung; C T Roberts; S Greenberg; G W Rebeck; R Christie; R Wallace; H J Jacob; B T Hyman
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

2.  Alzheimer's disease and apolipoprotein E-4 allele in an Amish population.

Authors:  M A Pericak-Vance; C C Johnson; J B Rimmler; A M Saunders; L C Robinson; E G D'Hondt; C E Jackson; J L Haines
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

3.  Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases.

Authors:  R E Tanzi; G Vaula; D M Romano; M Mortilla; T L Huang; R G Tupler; W Wasco; B T Hyman; J L Haines; B J Jenkins
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  Diagnostic usefulness of apolipoprotein E epsilon 4 in the diagnosis of the dementias.

Authors:  G B Frisoni; A Bianchetti; M Trabucchi; S Govoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

5.  Understanding Alzheimer's disease: expect more genes and other things.

Authors:  R Mayeux
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

6.  Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

Authors:  A M Saunders; O Hulette; K A Welsh-Bohmer; D E Schmechel; B Crain; J R Burke; M J Alberts; W J Strittmatter; J C Breitner; C Rosenberg
Journal:  Lancet       Date:  1996-07-13       Impact factor: 79.321

7.  Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

Authors:  D Scheuner; C Eckman; M Jensen; X Song; M Citron; N Suzuki; T D Bird; J Hardy; M Hutton; W Kukull; E Larson; E Levy-Lahad; M Viitanen; E Peskind; P Poorkaj; G Schellenberg; R Tanzi; W Wasco; L Lannfelt; D Selkoe; S Younkin
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

8.  Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world.

Authors:  L U Gerdes; I C Klausen; I Sihm; O Faergeman
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

9.  The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.

Authors:  S Wiggins; P Whyte; M Huggins; S Adam; J Theilmann; M Bloch; S B Sheps; M T Schechter; M R Hayden
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

10.  Apolipoprotein E and cognitive change in an elderly population.

Authors:  B T Hyman; T Gomez-Isla; M Briggs; H Chung; S Nichols; F Kohout; R Wallace
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422
View more
  1 in total

Review 1.  Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction.

Authors:  Jan Klysik; Steven J Theroux; John M Sedivy; Jeffrey S Moffit; Kim Boekelheide
Journal:  Cell Signal       Date:  2007-07-12       Impact factor: 4.315
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.